RxDoctor Payments Data

Elba Torres Matundan, MD

Anatomic Pathology & Clinical Pathology · San Juan, PRNPI 1629261110

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $7,380 of the $11,015 with a category attached, or 67.0%. 11 manufacturers reported payments, led by Agilent Technologies, Inc. at 40.9% of the total. Among anatomic pathology & clinical pathology clinicians in PR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,015in general payments, 2019–2025

Across 26 payments — averaging $423.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Agilent Technologies, Inc.$5K
  • Roche Diagnostics Corporation$3K
  • Merck$1K
  • AbbVie$1K
  • Amgen$344
  • Sanofi$150
  • plus $542 from 5 others

What the payments were for

  • Consulting fees$1,20011%
  • Speaking & faculty fees$7,38067%
  • Travel & lodging$8728%
  • Food & beverage$1,56314%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,015 in reported general payments places this provider in the 95th percentile of 48 anatomic pathology & clinical pathology providers in Puerto Rico.

See all anatomic pathology & clinical pathology providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$9,550
Medicare patients
24
Services billed
119

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in San Juan

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →